Course of Illness (COVID-19)
- Maryam Abdallah
Conditions
A41.9 Sepsis, unspecified organism D61.81 Pancytopenia D72.810 Lymphocytopenia D76.1 Hemophagocytic lymphohistiocytosis D76.2 Hemophagocytic syndrome, infection-associated R16 Hepatomegaly and splenomegaly, not elsewhere classified R59.9 Enlarged lymph nodes, unspecified R65 Symptoms and signs specifically associated with systemic inflammation and infection |
J18.9 Pneumonia, unspecified organism |
J80 Acute respiratory distress syndrome |
J95.851 Ventilator associated pneumonia |
N17.9 Acute kidney failure, unspecified |
Illness Severity
Known Deceased |
Moderate Illness Hospital Discharge Services Initial Hospital Inpatient Care Services Observation or Inpatient Care Services (Including Admission and Discharge Services) Subsequent Hospital Care Services 3E0F7GC Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Supplemental Oxygen (Derived UMLS:C4534306) |
Severe Illness Angiotensin II Cisatracurium Dexmedetomidine Dobutamine Dopamine Epinephrine Epoprostenol Ketamine Midazolam Milrinone Nitric Oxide / Nitrogen Norepinephrine Phenylephrine Propofol Rocuronium Vasopressin (Usp) Vecuronium Extracorporeal membrane oxygenation (ECMO) Intubation J80 Acute respiratory distress syndrome Mechanical Ventilation Carbon dioxide | blood arterial Oxygen | blood arterial |
Level of Care (Setting)
Ambulatory
Emergency
Inpatient (Critical Care)
Inpatient (Routine)
Medications
Ace Inhibitors
Anesthetics
Angiotensin II Inhibitor
Antibiotics
Anticoagulants
Antimalarials
Antineoplastics
Antivirals
Cardiovascular Agents, Other
Diagnostics, Other
Hormones/Sythetics/Modifiers
Immunosuppressants
Loop Diuretics
Neuromuscular Blocking Agents
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Platelet Aggregation Inhibitors
Sedatives/Hypnotics ,Other
Sympathomimetics (Adrenergics)
Other Variables of Interest
Abnormal Chest Imaging
Auto-Immune Disease
Chemotherapy
Flu Shot
Immunodeficiency
Influenza A/B Positive
Other Medications
Other Procedures
Pregnant
Transplant
Prognostic Lab Tests
Alanine aminotransferase | bld-ser-plas
Albumin | bld-ser-plas
Aspartate aminotransferase | bld-ser-plas
Bilirubin | bld-ser-plas
C reactive protein | bld-ser-plas
Carbon dioxide | blood arterial
Creatinine | bld-ser-plas
Ferritin | bld-ser-plas
Fibrin D-dimer DDU | Platelet poor plasma
Fibrin D-dimer FEU | Platelet poor plasma
Fibrinogen | platelet poor plasma
Lactate dehydrogenase | bld-ser-plas
Leukocytes | bld-ser-plas
Lymphocytes | bld-ser-plas
Neutrophils | bld-ser-plas
Oxygen | blood arterial
Procalcitonin | bld-ser-plas
Prothrombin time (PT) | platelet poor plasma
Troponin I.cardiac | bld-ser-plas
Troponin T.cardiac | bld-ser-plas
Respiratory Therapy Management
Extracorporeal membrane oxygenation (ECMO)
Intubation
Mechanical Ventilation
Supplemental Oxygen